These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 32268944

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of Four Validated Nomograms (Memorial Sloan Kettering Cancer Center, Briganti 2012, 2017, and 2019) Predicting Lymph Node Invasion in Patients with High-Risk Prostate Cancer Candidates for Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Clinical Experience and Review of the Literature.
    Di Pierro GB, Salciccia S, Frisenda M, Tufano A, Sciarra A, Scarrone E, Del Giudice F, Asero V, Bevilacqua G, Moriconi M, Carbone A, Pastore A, Signore S, Bove P, Forte F, Emiliozzi P, Tubaro A, De Nunzio C, Canale V.
    Cancers (Basel); 2023 Mar 09; 15(6):. PubMed ID: 36980571
    [Abstract] [Full Text] [Related]

  • 24. A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals.
    Bandini M, Marchioni M, Preisser F, Nazzani S, Tian Z, Fossati N, Gandaglia G, Shariat SF, Montorsi F, Saad F, Briganti A, Tilki D, Karakiewicz PI.
    Eur Urol Focus; 2019 May 09; 5(3):449-456. PubMed ID: 29249688
    [Abstract] [Full Text] [Related]

  • 25. Development of a novel nomogram incorporating platelet-to-lymphocyte ratio for the prediction of lymph node involvement in prostate carcinoma.
    Merhe A, Labban M, Hout M, Bustros G, Abou Heidar N, El-Asmar JM, Bulbul M, El Hajj A.
    Urol Oncol; 2020 Dec 09; 38(12):930.e1-930.e6. PubMed ID: 32736935
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Head-to-Head Comparison of Two Nomograms Predicting Probability of Lymph Node Invasion in Prostate Cancer and the Therapeutic Impact of Higher Nomogram Threshold.
    Venclovas Z, Muilwijk T, Matjosaitis AJ, Jievaltas M, Joniau S, Milonas D.
    J Clin Med; 2021 Mar 02; 10(5):. PubMed ID: 33801231
    [Abstract] [Full Text] [Related]

  • 28. External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study.
    Meijer D, van Leeuwen PJ, Roberts MJ, Siriwardana AR, Morton A, Yaxley JW, Samaratunga H, Emmett L, van de Ven PM, van der Poel HG, Donswijk ML, Boellaard TN, Schoots IG, Oprea-Lager DE, Coughlin GD, Vis AN.
    Eur Urol; 2021 Aug 02; 80(2):234-242. PubMed ID: 34024652
    [Abstract] [Full Text] [Related]

  • 29. Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer.
    Sabbagh A, Washington SL, Tilki D, Hong JC, Feng J, Valdes G, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Cowan JE, Cooperberg M, Feng FY, Roach M, Trock BJ, Partin AW, D'Amico AV, Carroll PR, Mohamad O.
    Eur Urol Oncol; 2023 Oct 02; 6(5):501-507. PubMed ID: 36868922
    [Abstract] [Full Text] [Related]

  • 30. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
    Godoy G, Chong KT, Cronin A, Vickers A, Laudone V, Touijer K, Guillonneau B, Eastham JA, Scardino PT, Coleman JA.
    Eur Urol; 2011 Aug 02; 60(2):195-201. PubMed ID: 21257258
    [Abstract] [Full Text] [Related]

  • 31. Validation of models predicting lymph node involvement probability in patients with prostate cancer.
    Blas L, Shiota M, Nagakawa S, Tsukahara S, Matsumoto T, Monji K, Kashiwagi E, Takeuchi A, Inokuchi J, Eto M.
    Int J Urol; 2022 May 02; 29(5):428-434. PubMed ID: 35102610
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Standardized and Simplified Robot-assisted Superextended Pelvic Lymph Node Dissection for Prostate Cancer: The Monoblock Technique.
    Mattei A, Würnschimmel C, Baumeister P, Hyseni A, Afferi L, Moschini M, Mordasini L, Grande P.
    Eur Urol; 2020 Sep 02; 78(3):424-431. PubMed ID: 32327264
    [Abstract] [Full Text] [Related]

  • 34. External Validation of the Briganti Nomogram to Predict Lymph Node Invasion in Prostate Cancer-Setting a New Threshold Value.
    Małkiewicz B, Ptaszkowski K, Knecht K, Gurwin A, Wilk K, Kiełb P, Dudek K, Zdrojowy R.
    Life (Basel); 2021 May 25; 11(6):. PubMed ID: 34070313
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms.
    Lodeta B, Baric H, Hatz D, Jozipovic D, Augustin H.
    BMC Urol; 2023 Nov 18; 23(1):190. PubMed ID: 37980520
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Transperineal template saturation and conventional biopsy for stage prediction in prostate cancer.
    Lehner F, Crippa A, Sigg S, Eberli D, Mortezavi A.
    BJU Int; 2023 Dec 18; 132(6):696-704. PubMed ID: 37704215
    [Abstract] [Full Text] [Related]

  • 39. Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms.
    Fossati N, Sjoberg DD, Capitanio U, Gandaglia G, Larcher A, Nini A, Mirone V, Vickers AJ, Montorsi F, Briganti A.
    BJU Int; 2015 Sep 18; 116(3):366-72. PubMed ID: 25168453
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.